Find participating medical centers and current study status in each of them

    Find participating medical centers

    A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis

    • Neurodegenerative Disorder
    • Relapsing Multiple Sclerosis (RMS)